SG11202000509PA - Nanostructured and biocompatible biocatalysts for use in cancer treatment - Google Patents
Nanostructured and biocompatible biocatalysts for use in cancer treatmentInfo
- Publication number
- SG11202000509PA SG11202000509PA SG11202000509PA SG11202000509PA SG11202000509PA SG 11202000509P A SG11202000509P A SG 11202000509PA SG 11202000509P A SG11202000509P A SG 11202000509PA SG 11202000509P A SG11202000509P A SG 11202000509PA SG 11202000509P A SG11202000509P A SG 11202000509PA
- Authority
- SG
- Singapore
- Prior art keywords
- nanostructured
- cancer treatment
- biocatalysts
- biocompatible
- biocompatible biocatalysts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5115—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762534748P | 2017-07-20 | 2017-07-20 | |
| PCT/IB2018/055335 WO2019016723A2 (en) | 2017-07-20 | 2018-07-18 | Nanostructured and biocompatible biocatalysts for use in cancer treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202000509PA true SG11202000509PA (en) | 2020-02-27 |
Family
ID=65015666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202000509PA SG11202000509PA (en) | 2017-07-20 | 2018-07-18 | Nanostructured and biocompatible biocatalysts for use in cancer treatment |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20200147029A1 (en) |
| EP (1) | EP3654949A4 (en) |
| JP (1) | JP2020528083A (en) |
| KR (1) | KR20200090733A (en) |
| CN (1) | CN111093636A (en) |
| BR (1) | BR112020001043A2 (en) |
| CA (1) | CA3070320A1 (en) |
| CL (1) | CL2020000130A1 (en) |
| CO (1) | CO2020001813A2 (en) |
| EC (1) | ECSP20013309A (en) |
| MX (1) | MX2019013038A (en) |
| PE (1) | PE20200753A1 (en) |
| SG (1) | SG11202000509PA (en) |
| WO (1) | WO2019016723A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200274190A1 (en) * | 2018-05-21 | 2020-08-27 | Innovasion Labs Pinc, Inc. | Parallel integrated nano components (pinc) & related methods and devices |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006344099B2 (en) * | 2006-06-06 | 2013-02-28 | Universidad Autonoma Metropolitana | Sol-gel nanostructured titania reservoirs for use in the controlled release of drugs in the central nervous system and method of synthesis |
| WO2010150036A1 (en) * | 2009-06-24 | 2010-12-29 | Universidad Autonoma Metropolitana - Xochimilco | Sol-gel nanostructured and biocompatible platinum-titania and platinum- silica biocatalysts nanostructured and biocompatible for use in cancer treatment |
| WO2011045627A1 (en) * | 2009-10-12 | 2011-04-21 | Arce Macias, Carlos, Francisco | Viricide agents having nanostructured biocatalysts materials of titanium dioxide (tio2) and silicium dioxide (si02) with platinum and iridium modified and dispersed on the surface |
| US9034882B2 (en) * | 2012-03-05 | 2015-05-19 | Bristol-Myers Squibb Company | Inhibitors of human immunodeficiency virus replication |
| MX339086B (en) * | 2013-06-20 | 2016-05-09 | Inmolecule Internat Ltd | Nanoparticulate titanium dioxide nanomaterial modified with functional groups and with citric extracts adsorbed on the surface, for the removal of a wide range of microorganisms. |
-
2018
- 2018-07-18 PE PE2020000090A patent/PE20200753A1/en unknown
- 2018-07-18 CA CA3070320A patent/CA3070320A1/en not_active Abandoned
- 2018-07-18 EP EP18835813.9A patent/EP3654949A4/en not_active Withdrawn
- 2018-07-18 JP JP2020524931A patent/JP2020528083A/en not_active Withdrawn
- 2018-07-18 MX MX2019013038A patent/MX2019013038A/en unknown
- 2018-07-18 BR BR112020001043-0A patent/BR112020001043A2/en not_active Application Discontinuation
- 2018-07-18 KR KR1020207005083A patent/KR20200090733A/en not_active Application Discontinuation
- 2018-07-18 WO PCT/IB2018/055335 patent/WO2019016723A2/en unknown
- 2018-07-18 SG SG11202000509PA patent/SG11202000509PA/en unknown
- 2018-07-18 US US16/632,846 patent/US20200147029A1/en not_active Abandoned
- 2018-07-18 CN CN201880059585.0A patent/CN111093636A/en active Pending
-
2020
- 2020-01-16 CL CL2020000130A patent/CL2020000130A1/en unknown
- 2020-02-19 CO CONC2020/0001813A patent/CO2020001813A2/en unknown
- 2020-02-20 EC ECSENADI202013309A patent/ECSP20013309A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3654949A2 (en) | 2020-05-27 |
| EP3654949A4 (en) | 2021-08-25 |
| JP2020528083A (en) | 2020-09-17 |
| BR112020001043A2 (en) | 2020-07-21 |
| ECSP20013309A (en) | 2020-09-30 |
| CN111093636A (en) | 2020-05-01 |
| PE20200753A1 (en) | 2020-07-27 |
| CO2020001813A2 (en) | 2020-05-29 |
| US20200147029A1 (en) | 2020-05-14 |
| WO2019016723A2 (en) | 2019-01-24 |
| CL2020000130A1 (en) | 2020-11-20 |
| KR20200090733A (en) | 2020-07-29 |
| WO2019016723A3 (en) | 2019-02-28 |
| MX2019013038A (en) | 2019-12-18 |
| CA3070320A1 (en) | 2019-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL270814A (en) | Antibody-cytokine engrafted proteins and methods of use in the treatment of cancer | |
| IL258725A (en) | Cd80 extracellular domain polypeptides and their use in cancer treatment | |
| HK1245287A1 (en) | IL13RAα2 BINDING AGENTS AND USE THEREOF IN CANCER TREATMENT | |
| IL272715A (en) | Engineered dnase enzymes and use in therapy | |
| ZA201904966B (en) | Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer | |
| IL282836A (en) | 5-halouracil-modified micrornas and their use in the treatment of cancer | |
| ZA201904967B (en) | Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer | |
| ZA201704726B (en) | Peptides and their use in the treatment of skin | |
| DK3681857T3 (en) | Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia | |
| IL281495A (en) | Quinuclidine-3-one derivatives and their use in cancer treatment | |
| GB201604213D0 (en) | Drug combination and its use in therapy | |
| GB201514021D0 (en) | Novel Pyridines and their use in the treatment of cancer | |
| IL272414A (en) | Use of gaboxadol in the treatment of diabetes and related conditions | |
| IL286334A (en) | Modified micrornas and their use in the treatment of cancer | |
| GB201820659D0 (en) | Novel compostions and their use in therapy | |
| GB201709840D0 (en) | Methods and medical uses | |
| SG11202004529XA (en) | Transformed human cell and use thereof | |
| PT3568397T (en) | Compounds and their use in the treatment of schistosomiasis | |
| IL269121A (en) | Usl-311 for use in the treatment of cancer | |
| GB201514015D0 (en) | Novel pyridazinones and their use in the treatment of cancer | |
| SG11202000509PA (en) | Nanostructured and biocompatible biocatalysts for use in cancer treatment | |
| EP3375445A4 (en) | Use of akt2 in diagnosis and treatment of tumor | |
| IL277038A (en) | Bexarotene derivatives and their use in treating cancer | |
| SG11202105276TA (en) | Oligo-benzamide analogs and their use in cancer treatment | |
| EP3687555A4 (en) | Tissue factor-targeting car-nk and car-t cell therapy |